JAK-STAT signaling in inflammatory breast cancer enables chemotherapy-resistant cell states.
Cancer Research
Stevens, Laura E LE; Peluffo, Guillermo G; Qiu, Xintao X; Temko, Daniel D; Fassl, Anne A; Li, Zheqi Z; Trinh, Anne A; Seehawer, Marco M; Jovanovic, Bojana B; Aleckovic, Masa M; Wilde, Callahan M CM; Geck, Renee C RC; Shu, Shaokun S; Kingston, Natalie L NL; Harper, Nicholas W NW; Almendro, Vanessa V; Pyke, Alanna L AL; Egri, Shawn B SB; Papanastasiou, Malvina M; Clement, Kendell K; Zhou, Ningxuan N; Walker, Sarah S; Salas, Jacqueline J; Park, So Yeon SY; Frank, David A DA; Meissner, Alexander A; Jaffe, Jacob D JD; Sicinski, Piotr P; Toker, Alex A; Michor, Franziska F; Long, Henry W HW; Overmoyer, Beth A BA; Polyak, Kornelia K
Publication Date: 2022-11-21
Variant appearance in text: AUP1: 524+100T>G; rs10779958
Beneficial effects of mifepristone treatment in breast cancer patients selected by the progesterone receptor isoform ratio: Results from the MIPRA trial.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Elía, Andrés A; Saldain, Leo L; Vanzulli, Silvia I SI; Helguero, Luisa A LA; Lamb, Caroline A CA; Fabris, Victoria V; Pataccini, Gabriela G; Martínez-Vazquez, Paula P; Burruchaga, Javier J; Caillet-Bois, Ines I; Spengler, Eunice E; Acosta Haab, Gabriela G; Liguori, Marcos M; Castets, Alejandra A; Lovisi, Silvia S; Abascal, María F MF; Novaro, Virginia V; Sánchez, Jana J; Muñoz, Javier J; Belizán, Jose M JM; Abba, Martín C MC; Gass, Hugo H; Rojas, Paola P; Lanari, Claudia C
Publication Date: 2022-10-21
Variant appearance in text: AUP1: 524+100T>G; rs10779958
Distinctive mutational spectrum and karyotype disruption in long-term cisplatin-treated urothelial carcinoma cell lines.
Scientific Reports
Skowron, Margaretha A MA; Petzsch, Patrick P; Hardt, Karin K; Wagner, Nicholas N; Beier, Manfred M; Stepanow, Stefanie S; Drechsler, Matthias M; Rieder, Harald H; Köhrer, Karl K; Niegisch, Günter G; Hoffmann, Michèle J MJ; Schulz, Wolfgang A WA
A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease.
Neurobiology Of Aging
Krüger, Rejko R; Sharma, Manu M; Riess, Olaf O; Gasser, Thomas T; Van Broeckhoven, Christine C; Theuns, Jessie J; Aasly, Jan J; Annesi, Grazia G; Bentivoglio, Anna Rita AR; Brice, Alexis A; Djarmati, Ana A; Elbaz, Alexis A; Farrer, Matthew M; Ferrarese, Carlo C; Gibson, J Mark JM; Hadjigeorgiou, Georgios M GM; Hattori, Nobutaka N; Ioannidis, John P A JP; Jasinska-Myga, Barbara B; Klein, Christine C; Lambert, Jean-Charles JC; Lesage, Suzanne S; Lin, Juei-Jueng JJ; Lynch, Timothy T; Mellick, George D GD; de Nigris, Francesa F; Opala, Grzegorz G; Prigione, Alessandro A; Quattrone, Aldo A; Ross, Owen A OA; Satake, Wataru W; Silburn, Peter A PA; Tan, Eng King EK; Toda, Tatsushi T; Tomiyama, Hiroyuki H; Wirdefeldt, Karin K; Wszolek, Zbigniew Z; Xiromerisiou, Georgia G; Maraganore, Demetrius M DM; ,
Genetic variation of Omi/HtrA2 and Parkinson's disease.
Parkinsonism & Related Disorders
Ross, Owen A OA; Soto, Alexandra I AI; Vilariño-Güell, Carles C; Heckman, Michael G MG; Diehl, Nancy N NN; Hulihan, Mary M MM; Aasly, Jan O JO; Sando, Sigrid S; Gibson, J Mark JM; Lynch, Timothy T; Krygowska-Wajs, Anna A; Opala, Grzegorz G; Barcikowska, Maria M; Czyzewski, Krzysztof K; Uitti, Ryan J RJ; Wszolek, Zbigniew K ZK; Farrer, Matthew J MJ